Melatonin as a Pharmacological Agent against Neuronal Loss in Experimental Models of Huntington's Disease, Alzheimer's Disease and Parkinsonism
Version of Record online: 6 FEB 2006
Annals of the New York Academy of Sciences
Volume 890, NEUROPROTECTIVE AGENTS: FOURTH INTERNATIONAL CONFERENCE pages 471–485, December 1999
How to Cite
REITER, R. J., CABRERA, J., SAINZ, R. M., MAYO, J. C., MANCHESTER, L. C. and TAN, D.-X. (1999), Melatonin as a Pharmacological Agent against Neuronal Loss in Experimental Models of Huntington's Disease, Alzheimer's Disease and Parkinsonism. Annals of the New York Academy of Sciences, 890: 471–485. doi: 10.1111/j.1749-6632.1999.tb08028.x
- Issue online: 6 FEB 2006
- Version of Record online: 6 FEB 2006
Options for accessing this content:
- If you are a society or association member and require assistance with obtaining online access instructions please contact our Journal Customer Services team.
- If your institution does not currently subscribe to this content, please recommend the title to your librarian.
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
- New Users: Please register, then proceed to purchase the article.
Login via OpenAthens
Search for your institution's name below to login via Shibboleth.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!